Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


The picture of health.

Lute K.

Newsweek. 2008 Dec 1;152(22):17. No abstract available.


B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cells.

May KF Jr, Chang X, Zhang H, Lute KD, Zhou P, Kocak E, Zheng P, Liu Y.

J Immunol. 2007 Feb 1;178(3):1542-52.


Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice.

May KF Jr, Lute K, Kocak E, Abdessalam S, Yin L, Li O, Guan Z, Philips G, Zheng P, Liu Y.

Blood. 2007 Jan 1;109(1):253-8. Epub 2006 Aug 8.


Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.

Kocak E, Lute K, Chang X, May KF Jr, Exten KR, Zhang H, Abdessalam SF, Lehman AM, Jarjoura D, Zheng P, Liu Y.

Cancer Res. 2006 Jul 15;66(14):7276-84.


Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.

Lute KD, May KF Jr, Lu P, Zhang H, Kocak E, Mosinger B, Wolford C, Phillips G, Caligiuri MA, Zheng P, Liu Y.

Blood. 2005 Nov 1;106(9):3127-33. Epub 2005 Jul 21.


Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.

Dakappagari NK, Lute KD, Rawale S, Steele JT, Allen SD, Phillips G, Reilly RT, Kaumaya PT.

J Biol Chem. 2005 Jan 7;280(1):54-63. Epub 2004 Oct 26.


Touch imprints: their use in the frozen-section diagnosis of alveolar soft-part sarcoma.

McDonald EC, Haughton W, Lute K.

Arch Pathol Lab Med. 1981 May;105(5):263-5.


Supplemental Content

Support Center